Mostrar el registro sencillo del ítem
| dc.contributor.author | Bernabeu-Mora,Roberto | |
| dc.contributor.author | Piedad-Sanchez-Martinez,M | |
| dc.contributor.author | Montilla-Herrador,Joaquina | |
| dc.contributor.author | Oliveira-Sousa,Silvana-L | |
| dc.contributor.author | Gacto-Sanchez,Mariano | |
| dc.contributor.author | Medina-Mirapeix,Francesc | |
| dc.date.accessioned | 2025-10-20T14:37:50Z | |
| dc.date.available | 2025-10-20T14:37:50Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Bernabeu-Mora R, Sánchez-Martínez MP, Montilla-Herrador J, Oliveira-Sousa SL, Gacto-Sánchez M, Medina-Mirapeix F. 2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages. COPD. junio de 2020;Volume 15:1519-27. | |
| dc.identifier.issn | 1178-2005 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/20434 | |
| dc.description.abstract | Background: Despite wide use of the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) 2011, little is known about between-stage transitions and what factors predict worsening transitions in patients with chronic obstructive pulmonary disease (COPD).Objective: To investigate the transition frequency between GOLD 2011 stages among patients with stable COPD over a 2-year follow-up, to identify potential non-pulmonary predictor factors for worsening transitions, and to compare transition frequencies between GOLD 2011 stages and the new GOLD 2017 stages.Patients and Methods: We prospectively included 137 patients with stable COPD (mean age, 66.9 +/- 8.3 years). GOLD 2011 and GOLD 2017 stages were measured at baseline, 1-year follow-up, and 2-year follow-up. To evaluate non-pulmonary variables as potential predictors of worsening transitions, we used regression models adjusted for sociodemographic, clinical, and pulmonary variables using generalized estimating equations.Results: The study period included 246 opportunities for transition, and 39 worsening transitions occurred within GOLD 2011 stages. Predictors of worsening transitions included BODE index (OR, 1.20; 95% CI, 1.00-1.44), quadriceps strength (OR, 0.87; 95% CI, 0.76-0.99), and limited mobility activities (OR, 1.02; 95% CI, 1.00-1.05). The frequency of worsening transitions for stages B and C differed between GOLD 2011 and GOLD 2017. Stages A and D were the most stable in both classifications.Conclusion: Non-pulmonary factors predicted worsening transitions among the GOLD 2011 stages of COPD severity. The choice of GOLD 2011 versus GOLD 2017 may influence transition identification, especially for stages B and C. | |
| dc.language.iso | eng | |
| dc.publisher | DOVE MEDICAL PRESS LTD | |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Pulmonary Disease, Chronic Obstructive/diagnosis/epidemiology | |
| dc.subject.mesh | Severity of Illness Index | |
| dc.title | 2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 32636620 | |
| dc.relation.publisherversion | https://dx.doi.org/10.2147/COPD.S254434 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.2147/COPD.S254434 | |
| dc.journal.title | International Journal of Chronic Obstructive Pulmonary Disease |